MedTrace Logo

To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Insufficiency

NCT05424653 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-06-21

No results posted yet for this study

Summary

To Evaluate the Safety and Effectiveness of Transcatheter Aortic Valve System ( Chengdu Silara Medtech Inc. ,Chengdu, China)in Patients with Severe Symptomatic Aortic Insufficiency

Conditions

  • Aortic Insufficiency

Interventions

DEVICE

Transcatheter Aortic Valve System

Procedure: Transcatheter Aortic Valve Replacement

Sponsors & Collaborators

  • Chengdu Silara Meditech Inc.

    lead INDUSTRY

Principal Investigators

  • Jincheng Liu · The First Affiliated Hospital,the Air Force Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2022-12-01
Completion
2023-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05424653 on ClinicalTrials.gov